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Background: The maternal cardiovascular system adapts quickly when embryo implantation is recognized by the
body. Those adaptations play an important role, as a normal cardiovascular adaptation is a requirement for a
normal course of pregnancy. Disturbed adaptations predispose to potential hypertensive disorders further in
pregnancy [1–3]. This report aims to briefly inform the obstetricians, general practitioners and midwives, who are
the key players in detecting and treating hypertensive disorders during pregnancy.
Methods: The PubMed database was used as main tool to find studies involving clearly defined first trimester
hemodynamic changes in normal pregnancies and hypertensive pregnancies. In addition, the bibliographies of
these studies were investigated for further relevant literature.
Results: A comprehensive overview is given concerning the normal adaptations in the cardiovascular tree in a first
trimester pregnancy. Additionally, signs of abnormal cardiovascular changes observed in first trimester are described
together with the normal reference range for each non-invasive, easily applicable technique for maternal
hemodynamics assessment.
Conclusions: With a combination of techniques, it is possible to integrate and evaluate the maternal heart, veins
and arteries at 12 weeks of pregnancy. Applying those techniques into the daily clinic opens perspectives to
prevention and prophylactic treatment, aiming for a reduction of the risk for hypertension during pregnancy.
Keywords: Maternal hemodynamics, First trimester, Hypertension, Reference values, Early pregnancyBackground
A normal pregnancy is characterized by multiple cardio-
vascular adaptations to provide optimal conditions for
fetal growth and development. Most of these changes
are induced shortly after embryo implantation and thus
well before the exponential increase of the fetal and pla-
cental demands for oxygen and nutrients, predominantly
occurring in the second half of pregnancy. Most circula-
tory functions have changed significantly by the end of
the first trimester [1].
A maladaptation in any step of the process changes
the structural, physiological or metabolic environment of
the fetus. The genetic program of the fetus induces* Correspondence: sharona.vonck@zol.be
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influences the fetus’ cardiovascular system in later life
[2]. Additionally, those disturbed physiological processes
predispose to pregnancy complications, such as pre-
eclampsia and fetal growth restriction [3].
This review provides a summary of the most relevant
cardiovascular changes in the first trimester of a normal
pregnancy, as reported in diverse studies done in early
pregnancy. Adaptations are presented and discussed at
each part of the cardiovascular tree, the arteries, veins
and heart. Additionally, a comprehensive overview is
given about the pathology-specific features of hyperten-
sive disorders, measurable in the first trimester, together
with the normal values of each non-invasive, easily ap-
plicable technique.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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The cardiovascular function in women varies with the
menstrual cycle. In the luteal phase, heart rate, plasma vol-
ume, cardiac output (CO), central and peripheral arterial
compliance and distensibility have increased relative to the
follicular phase. Meanwhile, mean arterial pressure (MAP)
has decreased together with the vascular resistance. Chap-
man suggests that the fall in peripheral vascular resistance
is the primary event in the luteal phase. Afterwards, the
MAP decrease initiates a hemodynamic compensation
through a rise in CO. Due to a dilated vascular system, the
renal plasma flow and glomerular filtration rate increase
and an activation of the renin-angiotensin-aldosterone sys-
tem (RAAS) during the luteal phase is seen [4, 5].
This cyclic pattern resembles roughly to the simultan-
eous hormonal variations occurring during the men-
strual cycle, which suggests prudently a role for estrogen
in modulating the vascular smooth muscle tone. Estro-
gen has been shown to enhance endothelial function, di-
late arterioles, vascular smooth muscle cell proliferation,
inhibit fibroblast and collagen accumulation in the aortic
wall [6]. The exact mechanism by which estrogens mod-
ulates arterial function has been explored in animal
studies: vascular smooth muscle cells have estrogen re-
ceptors [7] and estrogen administration induces vaso-
dilatation [8]. It is however difficult to postulate a direct
relation between estrogen and cardiovascular events, as
other factors (like nitric oxide, relaxin, vascular endothe-
lial growth factor, prostanoid metabolites, adhesion mol-
ecules, etc.) also vary during the menstrual cycle. It is
probably a complex cascade of events which initiates the
primary vasodilation [9].
Early pregnancy is characterized by vascular relaxation
along with increased arterial compliance and distensibility.
The pattern of cardiovascular changes in the luteal phase
relative to the follicular phase of the menstrual cycle re-
semble those in early pregnancy. From conception until
the 7th week of pregnancy, the maternal endocrine envir-
onment is dominated by the extended function of the cor-
pus luteum, which is activated through the release of large
amounts of human chorionic gonadotropin (hCG). Conse-
quently, the hemodynamic and hormonal changes seen in
the first weeks of gestation are independent of a function-
ing fetal-maternal-placental unit [5].
Cardiovascular changes
5 weeks of gestation
Doppler echography at the level of the pulmonary, mi-
tral and aortic valves at 5 weeks pregnancy showed con-
sistently higher values for heart rate and cardiac output
relative to the prepregnant state (luteal phase) [10, 11],
whereas others reported a rise in cardiac output occur-
ring later on in the first trimester [12] or not at all [13].
This discrepancy might be explained by the absence of apre-pregnancy baseline [12] or the different measuring
time points and design of the study [13]. Both heart rate
and cardiac output increase steadily in the course of the
first trimester [10, 12].
Cardiac output depends on heart rate, contractility,
preload and afterload. Consequently, the initial increase
in cardiac output is achieved by a rise in a higher heart
frequency [10, 14], simultaneously with the reduction in
peripheral vascular resistance [10–12]. Peripheral vascu-
lar resistance decreases abruptly by 20–25 % at 5 weeks
compared to the beginning of the menstrual cycle [11],
most likely in concert with an abrupt fall in plasma
osmolality [15]. Also stroke volume and plasma volume
are reported to be increased at week 5, indicating that
all these adaptive changes contribute to the prolonged
institution of a high cardiac output and low peripheral
resistance circulation [10, 16].
6 weeks of gestation
At 6 weeks pregnancy, the magnitude of systemic vasodila-
tation had increased relative to 5 weeks [17] with lower
blood pressures (systolic + diastolic, brachial and central)
than before conception, occurring secondary to the periph-
eral vasodilation. This event arises together with an add-
itional fall in pulse wave velocity, a parameter correlating
with aortic stiffness [1, 12, 18]. Systolic and diastolic blood
pressure continue to decrease until 24 weeks of gestation,
because the CO incline is not sufficient to prevent the
blood pressure fall as blood pressure is the product of car-
diac output and total peripheral vascular resistance [17].
Shortly after implantation, the corpus luteum releases
plasma relaxin, which is 3–4 fold higher at 6 weeks than
during the menstrual cycle. Relaxin circulates in the ma-
ternal blood and rapidly reaches a plateau at the end of
the first trimester. It is suggested to play a role in the
vasodilation pathway, but the exact pathway is still un-
clear. The vasodilatory response of relaxin is mediated by
its major receptor (relaxin/insulin-like family peptide 1 re-
ceptor, RFXP1) and depends on duration of hormone ex-
posure. The rapid vasodilatory responses are performed
through the activation of the pathway stimulating nitric
oxide synthase. The sustained vasodilatory response relies
on vascular endothelial and placental growth factors and
the arterial gelatinase activity [19].
Renal hemodynamics are also characterized by a marked
fall in renal vascular resistance, giving rise to a correspond-
ingly increase in renal perfusion [20]. The latter induces a ≈
50 % rise in glomerular filtration rate (GFR) accompanied
by a small decline in filtration fraction. Meanwhile, the low
blood pressures activate renin-angiotensin-aldosterone sys-
tem (RAAS), which increases plasma renin activity and
plasma aldosterone. Angiotensin II induces constriction of
the renal blood vessels, excretion of the vasopressin hor-
mone and aldosterone/adrenaline/noradrenaline production.
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duction, leads to sodium and water reabsorption. The vaso-
pressin hormone prevents re-excretion of the water [21].
This causes the expansion of plasma volume, hemodilution,
a higher renal plasma flow and a higher cardiac output [18,
22]. Cardiac preload (i.e. venous return) increases in concert
with the plasma volume expansion. This improves cardiac
filling during diastole, which raises the efficiency of the
Frank-Starling mechanism. Due to concomitant fall in car-
diac afterload, a higher stroke volume arises and the ele-
vated cardiac output is preserved, which anticipates an
adequate fetal and placental supply of oxygen and nutrients
throughout the course of pregnancy. These changes occur
long before the uteroplacental circulation has become an
important part of the systemic circulation [18, 23, 24].
7 weeks of gestation
At 7 weeks of gestation an increasing distensibility and
compliance of the arterial and venous compartment has
been observed [11, 25, 26]. It is suggested that the arterial
compliance increases due to relaxation of the muscular
wall of the vessels [11, 26]. The decrease in peripheral vas-
cular resistance causes a decrease in diastolic pressure,
but the presence of a higher arterial compliance counter-
balances this event, assuring normalized perfusion pres-
sure to coronaries and vital organs [26, 27]. Both events
may play a role in enhancing the left ventricular perform-
ance [25]. A higher venous compliance increases the cap-
acity of the venous compartment to accommodate a larger
reserve volume in the splanchnic system, which is also ne-
cessary to preserve the cardiac output during pregnancy
[28]. The venous compliance keeps on rising by advancing
pregnancy [29].
8 weeks of gestation
Due to the increasing cardiac preload together with the
lower afterload early in pregnancy, stroke volume and
cardiac output keep on rising during the first trimester
[10]. The continuous increase of cardiac output is from
this moment not only caused by a higher heart rate, but
is supported by the increase in stroke volume together
with the observed anatomic increase of the heart surface
area [12, 14]. The left atrial diameter increases together
with the left ventricular diastolic dimension, which is a
measurement of the preload [12]. The systolic dimension
of the left ventricle and the ventricle wall thickness were
also significantly increased [10, 14]. These changes en-
hance the performance of the total left ventricle [12]. The
aortic, pulmonary and mitral velocities increase steadily
and become significantly higher in week 8 as compared to
pre-pregnancy values [10]. The onset of intervillous perfu-
sion with maternal blood, starting to develop at ≈ 8 weeks,
is not only associated with a rise in the intervillous oxygen
tension, but also with a rise in the circulating levels of anumber of placental biochemical markers for oxidative
stress [30].
9 to 12 weeks of gestation
At 8 weeks, the first morphological changes have been
reported in multiple studies. At 12 weeks, Doppler echocar-
diography indicated more advanced changes in the heart
surface area: the mitral, aortic and pulmonary valve areas
increase, together with diastolic dimensions, left atrial di-
mensions, total left ventricle wall thickness and left ventricle
mass [10]. Left ventricular diastolic and systolic volumes are
both increased comparing to pre-pregnancy, but not yet sig-
nificant according to the first trimester study of Del Bene
[13]. The increase of the cardiac dimensions are probably a
consequence of the persistent increase of venous return and
cardiac filling pressure, which can be expected to improve
the cardiac performance continuously [10]. Cardiac output,
blood volume and plasma volume are highest at 12 weeks
in the first trimester, which might explain why most mor-
phological heart changes only become significant around
12 weeks [18]. The progressive enlargement of the heart
surface area represents the typical gestational phenomenon
‘myocardial eccentric hypertrophy’. This is a reversible
hypertrophy without any long term cardiac consequences
[10, 31]. Interestingly, all these pregnancy-related cardiac
changes are identical to patients with a chronic volume
overload state and in isotonic-exercising athletes (swim-
ming, running) 10 to 12 weeks after the start of the training
program: higher left ventricle volume, left ventricle mass
and ventricular performance [32].
In the first trimester, renal plasma flow (RPF) reaches
a peak at 12 weeks. Afterwards RPF decreases. Glomeru-
lar filtration rate had increased steadily in the first tri-
mester, continues to increase in the second trimester but
tends to decline again in the third trimester. Atrial natri-
uretic peptide (α-ANP) is significantly raised at week 12,
and keeps increasing even more afterwards. It has diuretic,
natriuretic and vasodilator properties and might play an
important role in volume homeostasis [18]. α-ANP is con-
sidered not active in early pregnancy because plasma con-
centrations remain low during the first weeks, but increase
by 35 % in the second trimester in association with the
plasma volume increase. This suggests that plasma α-ANP
changes are secondary to the plasma volume increase, ra-
ther than playing a primary role in the hemodynamic
changes [12, 18].
In the second half of the first trimester, retrograde
trophoblast invasion into the spiral artery together with
a lower responsiveness to vasoconstrictor agents may ex-
plain the further rise in uteroplacental vascular compli-
ance, as the resistance index (RI) and pulsatility index
(PI) of the uterine artery decrease when gestational age
increases. RI and PI are representative for the resistance
in the uterine arteries. There exists an inverse relation
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into the spiral arteries [33, 34] Intervillous blood flow be-
comes only detectable from 12 weeks onwards, because
trophoblastic migration is only observed from week 10, and
a consecutive formation into the myometrium of the spiral
arteries starts from week 14. This implies that physiological
changes are completed and heart/vessels are adapted mor-
phologically. Spiral arteries remodeling induces the change
from high-resistance flow to low-resistance flow [30]. Also
further studies have shown a continuous decrease of re-
sistance and pulsatility indices between 12 and 16 weeks
[35–37] (Table 1).Pathological signs in the first trimester
The cardiovascular system in patients with hypertensive
disorders differs from the normal maternal cardiovascular
system. Focusing on hemodynamic characteristics could
help to understand the physiological maladaptations in the
first trimester.Table 1 Overview of all early cardiovascular changes in normal preg
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Peripheral arteries
Higher uterine pulsatility indices in early preeclampsia
than uncomplicated pregnancies have been reported in
the early pregnancy (2.35 vs. 1.79), which is a measure-
ment for impaired placentation and arterial stiffness [38].
Additionally, placental volume was shown to be smaller
too in (early) preeclamptic patients (60 vs. 43 cm3) [38]. In
patients developing late preeclampsia however no aber-
rant uterine pulsatility indices or placental volume were
found [38]. There is a direct relation between resistance,
arterial stiffness and endothelial dysfunction, which clinic-
ally presents in high blood pressures. This is in congru-
ence with measurements for total vascular resistance,
which was shown to be higher in the late preeclamptic
group (1105 dyne*sec*cm−5 versus 1260 dyne*sec*cm−5),
measured as [MAP (mmHg)/CO (L/min) x 80] [39]. An-
other measurement for arterial stiffness is the pulse wave
velocity (PWV) and augmentation index (AIx). Already at
the end of the first trimester, the pulse wave velocity andnancy
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higher in the hypertensive group (7.47 m/s vs. 6.55 m/s
(PWV); 13.2 % vs. 10.6 % (AIx)) [40]. Peripheral higher
blood pressures (diastolic, systolic, mean arterial pressure)
could be measured (123 vs. 114 mmHg (SBP); 82 vs.
75 mmHg (DBP); 92 vs. 85 mmHg (MAP)) in an eventual
late hypertensive group [41]. All those results indicate a
stiffer peripheral arterial system already in the first trimes-
ter of pregnancies destined to develop pre-eclampsia.Central arteries
Additionally, the early gestational central systolic blood
pressure is also higher in the preeclamptic group
(122 mmHg vs. 108 mmHg) [40]. First trimester aorta
flow parameters (velocity index (VI), acceleration index
(ACI) and heather index (HI)), which are directly re-
lated to systolic function and aorta compliance, are
shown to be different between normal and pathological
pregnancies (VI: 72 vs. 57 1/1000/s; ACI: 133 vs. 108 1/
100/s2; HI: 23.1 vs. 17.3Ω/s2). Lower values, as seen in
the late hypertensive group, reflect a poor ventricular
ejection and thus systolic dysfunction already present
in the first trimester [41].Heart
Khaw et al. investigated different cardiovascular func-
tions at 11–14 weeks between uncomplicated pregnan-
cies, eventual preeclamptic pregnancies with appropriate
for gestational age babies (AGA) and preeclamptic patients
with small for gestational age babies (SGA). Cardiac output,
cardiac index and stroke volume were significantly higher
in the preeclamptic group with AGA than the uncompli-
cated group (6.2 l/min, 3.3 l/min/m2, 87.9 ml versus 4.9 l/
min, 2.9 l/min/m2, 67 ml resp.) [39, 42]. A higher mitral
valve annulus shortening is also found in this pathological
group (15.5 mm versus 17.8 mm), supporting this sugges-
tion. Preeclampsia with SGA babies have no aberrant car-
diac output, cardiac index or stroke volume parameters
(4.9 l/min, 2.8 l/min/m2, 66.3 ml resp) compared to the un-
complicated group [39]. Further, higher values are observed
for mitral valve E-wave velocity (82.4 mm/s versus
95.7 mm/s) in the late preeclamptic group. Mitral valve E-
wave velocity measures the diastolic function, which is the
passive filling of the ventricle. Khaw et al. also measured
the mitral valve A-wave velocity (representation of the
active filling during atrial systole), which did not differ sig-
nificantly between the 2 groups in this study [39]. Both vel-
ocities are strongly dependent from physiological changes
in heart rate, preload, left ventricular compliance and con-
tractility. An initial rise in the E/A ratio is consistent with
an initially impaired adaptation of cardiac diastolic function,
which is already present in a first trimester measurement in
the hypertensive group. An increase of more than 7 % at12 weeks indicates an important higher risk for pre-
eclampsia [43].
Veins
Also venous impedance is observed to be higher in
pathological pregnancies than normal pregnancies. A
high venous impedance is accompanied with a low ven-
ous distensibility, a higher venous pressure, a lower ven-
ous capacity and a smaller increase in plasma volume
[44]. However, venous hemodynamic function is shown
to be normal in the first trimester, but becomes abnor-
mal during the second trimester in the pregnancies des-
tined to develop preeclampsia [41].
Hematology
Plasma volume increase is very important for normal
fetal development. Maladaptation of the cardiovascular
system can obstruct a necessary increase in plasma vol-
ume. There is a correlation between maternal cardiac
output and the growth of the fetus, already present in
the first trimester [45]. The link between cardiac output
and birth weight percentiles is associated with the grade
of heart, vein and artery dysfunction because those are
the driving forces of the cardiac output [45].
Kidney
A direct consequence of a high vascular resistance and
high blood pressure is the decrease in renal perfusion
and glomerular filtrate rate. The renal clearance will de-
crease, which leads to a higher plasma concentration of
uric acid. Preeclampsia is characterized by proteinuria,
which possibly relates to a higher capillary pressure in
the glomerular filter. This induces a lower tubular ab-
sorption, contributing to glomerular endotheliosis. How-
ever, no studies are found concerning this topic in first
trimester [46].
Aberrant hemodynamic characteristics may already
be evident in the first trimester, however not always
measurable. More and more researchers focus on
well-defined subject groups, as the pathophysiology
between gestational hypertension, early preeclampsia
and late preeclampsia with and without intra uterine
growth restriction have important hemodynamic
differences.
Techniques: normal values
To assess abovementioned maternal cardiovascular adapta-
tions, safe, easily accessible and non-invasive first trimester
techniques are useful, which have the potential to evaluate
the different compartments of the maternal cardiovascular
system.
A Doppler ultrasound of the uterine artery is a widely
used, non-invasive technique to measure the pulsatility
index (PI; [peak systolic flow – end diastolic flow/mean
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end diastolic flow/peak systolic flow) from the flow vel-
ocity waveforms of the uterine arteries. Normal values
vary between 0.56 and 0.76 for RI, and minimum 1.11
and maximum 2.08 for PI [33, 35, 39–41, 47, 48]. Low
end-diastolic velocities and an early diastolic notch are
typical waveforms in the first trimester pregnancy, indi-
cating a high uterine resistance [47, 49, 50]. Other pa-
rameters reflecting arterial stiffness is the pulse wave
velocity, measured from artery pulse waveforms in the
brachial [40, 51, 52] or radial artery [53]. SphygmoCor
(West Ryde, Australia), Complior (Vincennes, France) or
Arteriograph (TensioMed, Budapest, Hungary) are the
three techniques used for pulse wave analysis. The nor-
mal pulse wave velocity ranges between 6.13 and
8.13 m/s. PI, measured with the artery pulse waveform
technique, lies between 1.4 and 2.08 [40, 51]. In pre-
eclampsia, PI, RI and pulse wave velocity are consider-
ably higher [38–41, 53–55].
The combination of electrocardiogram and Doppler
ultrasound is used to investigate the maternal venous sys-
tem (renal interlobular veins and hepatic veins), using ven-
ous impedance indices and the ‘venous pulse transit time’
(VPTT). Tomsin et al. reported a gradual rise of the VPTT
in normal pregnancy and a significantly shorter VPTT
in preeclamptic patients, which illustrates a venous
hemodynamic dysfunction in preeclampsia [56, 57]. Also
aberrant venous impedance indices (Hepatic Vein Index
(HVI), Renal Interlobar Vein Index (RIVI)) are seen in the
active phase of preeclampsia. Compared to normal preg-
nancies, in the preeclamptic group at 12 weeks, the ven-
ous function seems to be normal [VPTT kidney: 0.24–
0.35 ms; VPTT liver: 0.13–0.23 ms; HVI: 0.7–1.6; RIVI:
0.38–0.56] [41].
Aortic Doppler flow measurements estimate the aortic
valve area, cardiac output and stroke volumes. The aortic
area has a normal range from 3.85 to 3.94 cm2. Stroke vol-
ume with this technique is reported between 81.5 and
84.1 ml, and cardiac output between 6.61 and 6.83 l/min
[10]. In (late) preeclampsia, stroke volume and cardiac
output are higher [39, 42]. Aortic valve area uses calcula-
tions from the aortic diameter, which is reported to be
higher in preeclampsia in the first trimester [58].
Echocardiography is the preferred technique to evalu-
ate the systolic and diastolic function of the heart dur-
ing the complete course of pregnancy. Cardiac output,
stroke volume (systolic function); E-wave and A-wave
(diastolic function) and mitral valve annulus shortening
measurement are parameters measured with this tech-
nique. Diastolic function has an E-wave range from
68.8 to 96 mm/s, and an A-wave range from 40.5 to
57.3 mm/s. The mitral valve annulus is found to be
normal between 13.5 and 17.5 mm [39]. Robson et al.
measured also left ventricle End-Systolic Dimension(ESD), ranging from 2.85 to 2.91 cm, and End-Diastolic
Dimension (EDD), ranging from 4.63 to 4.69 cm. The
Left Atrial Dimension (LAD) ranges between 3.26 and
3.36 cm. Further, the thickness of the left ventricle wall
is measured, as 1.56–1.62 cm, and the mass: 134–140 g.
The ejection fraction is 75.7–76.9 %, all parameters
measured around 12 weeks [10]. In preeclampsia, in-
creased mitral valve shortening and E-wave are re-
ported, but significant differences in ESD, EDD, LAD,
left ventricular wall thickness and mass were not ob-
served [43].
Other systolic parameters can be measured by impedance
cardiography, which monitors the cardiovascular changes
by transmitting an electrical current with high frequency
and low amplitude through the maternal thorax. Another
non-invasive method is the USCOM (Sydney, Australia)
device which measures the velocity of the aortic/pulmonary
blood flow, used to calculate a time-velocity integral, and as
such basically is a derived echocardiography technique. In
these cases, cardiac output and stroke volume seem to have
an overestimation with those two techniques relative to
echocardiography measurements as the normal range for
CO is reported around 6.48–7.89 l/min, and for SV 72.62–
94.62 ml. Echo cardio measurements are lower: CO 4.3–
5.5 l/min, and SV 55.3–78.7 ml. Non-Invasive Cardiac Out-
put Monitor (NICOM, Cheetah Medical, USA) also
measures HR, CO and SV. It is based on a thoracic
bioreactance technology, but no published studies on
patients in the first trimester of pregnancy were traced. It is
still quite controversial using non-invasive techniques in
clinics, as the reliability compared to the golden standard
echocardiography is highly discussed in literature.
However, using only one technique with its method-
specific reference values eliminates possible over- or
underestimation [39, 41, 55, 59]. With the use of the
formula: [(MAP(mmHg)/CO(L/min) x 80], total per-
ipheral resistance (dyne*sec*cm−5) can also be calculated
(1015–1212) [10, 39]. With the USCOM device, this param-
eter is automatically measured using a non-reported
formula and the range is found to be slightly lower
(940.87–1118.53) [55]. Impedance cardiography add-
itionally provides some important aorta flow parame-
ters: aorta velocity index (1/1000/s), acceleration index
(1/100/s2) and heather index (Ω/s2). In the first trimes-
ter, those parameters have an important implication.
Normal values are seen between 62 and 82; 107 and
156; 19.2 and 26.9 respectively. In preeclampsia, aortic
flow measurements are in a lower range [41].
Studies using echocardiography, impedance cardiog-
raphy and USCOM additionally measured the blood
pressures. Normal systolic blood pressures at 12 weeks
vary from 107 to 122 mmHg, diastolic blood pressures
range from 65 to 77 mmHg. The mean arterial pressure
lies between 77 and 86 mmHg. Heart rates range in the
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eclampsia, first trimester blood pressures and heart rate
are already slightly higher than normal [39, 41, 53–55]
(Table 2).
Application of techniques
Together with gaining basic knowledge about the nor-
mal physiological cardiovascular changes in the first tri-
mester of pregnancy, all techniques discussed above
allow investigating a population of 12 week pregnant
women non-invasively, which opens a window to screen
for hypertensive disorders. With a combination of tech-
niques, it is possible to integrate and evaluate the mater-
nal heart, veins and arteries at 12 weeks of pregnancy
[41]. In this review, normal values are summarized
which opens easily future perspectives to search for aber-
rant cardiovascular signs in each part of the cardiovascular
tree of the doctors patients. Screening for hypertensive
disorders is very useful as an early stratification into a high
risk vs. a low risk group is possible. Possible follow-up or
treatment strategies could be based on prescribing low-
dose aspirin before 16 weeks of gestation, which is associ-
ated with a 50 % reduction of PE risk and 80 % of early PE
[60, 61], paying attention to regular physical activity dur-
ing pregnancy [62] or remote blood pressure monitoringTable 2 Normal reference values of different non-invasive technique
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MAP Mean Arterial Pressure, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressu
Heart Rate, MVAS Mitral Valve Annulus Shortening, E-wave E-wave velocity, A-wave
LAD Left Atrial Dimension, LV Left Ventricle, EF Ejection Fraction, ACI Acceleration In
RIVI Renal Interlobar Vein Index, HVI Hepatic Vein Index, VPTT Venous Pulse Transit[63]. Applying those techniques into the daily clinic opens
perspectives to prevention and prophylactic treatment,
aiming for a reduction of the risk for hypertension during
pregnancy. In the long run, it may reduce significantly the
maternal and neonatal morbidity and mortality associated
with hypertensive disorders [64, 65]. It should however
be emphasized that in this review all described
hemodynamic changes with corresponding normal or
hypertensive values reflect average values, which are
subject to individual variability.Conclusion
Many recent studies disclose the fact that initiation of
placentation is not a necessary step for the normal or
pathological hemodynamic alterations in a pregnancy, as
placentation starts later than the very first maternal
hemodynamic changes. This emphasizes the important
role of the maternal cardiovascular system during gesta-
tion, with a normal hemodynamic adaptation as a
requirement for a normal course of pregnancy. Today,
many non-invasive techniques allow a detailed assess-
ment of maternal cardiovascular adaptations which
opens perspectives to early postconceptional screening








































re, TVR Total Vascular Resistance, CO Cardiac Output, SV Stroke Volume, HR
A-wave velocity, ESD End-Systolic Dimension, EDD End-Diastolic Dimension,
dex, VI Velocity Index, HI Heather Index, PI Pulsatility Index, RI Resistivity Index,
Time, PWV Pulse Wave Velocity
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